Cervical Screening in NSW: Annual Statistical Report 2008-2009
This report provides information and statistics on the number of women participating in cervical screening in NSW and the impact of cervical cancer on the community, including new cases and the number of deaths from the disease.
Cervical cancer affects the cells of the cervix, which is the lower part of the uterus where it joins the inner end of the vagina. Like other cancers, cervical cancer is a disease where normal cells change, begin to multiply out of control, and form a growth or tumor. Cervical cells however exhibit precancerous abnormalities which can be detected through screening before possible progression to cancer occurs.
During the past decade a greater understanding of the natural history of cervical cancer has developed. It is now recognised that cervical cancer is a rare outcome of persistent infection with human papillomavirus (HPV), and that infection with a high-risk HPV type is necessary, although not sufficient, for the development of cervical cancer.
Cervical screening, as a means of early detection of cervical cancer, has been a very successful public health achievement in the modern era. It is estimated to be more than 90 per cent effective in preventing cases of cervical cancer in women.
- In 2008-09, 1,363,969 women had Pap tests in NSW
- Of these, 1,308,737 tests were in women of the target age group of 20-69 years
- The biennial participation rate of 57.5% is the percentage of NSW women aged 20-69 years who underwent a Pap test in the biennial period; from 1 January 2008 to 31 December 2009. The highest biennial screening rate (58.3%) was observed in women living in the 'Inner Regional' areas and the lowest (48.1%) in 'Very Remote' areas.
- In 2008 there were 248 new cases of cervical cancer (all ages) with an age standardised incidence rate of 6.7 per 100,000 women. In the ten year period: 1999-2008 the age-standardised incidence rate fell by 19.7%.
- In 2008 there were 101 cervical cancer deaths. The age standardise mortality rate was 2.5 per 100,000 women. This is an increase from 2007 (1.8 per 100,000).
National Cervical Screening Program
The National Cervical Screening Program (NCSP) commenced in 1991 and operates as a joint program of the Australian and state and territory governments. The NCSP aims to screen women aged 20-69 years.
The NSW Cancer Institute monitors and reports on the performance of the NCSP. The latest publication, Cervical Screening in NSW: Annual Statistical Report 2008-2009, provides information on cervical cancer screening for cervical cancer providers, researchers, planners, academics, students and for the people of NSW.
For further details or comments, contact Cervical Screening NSW.